Disclosed are compounds which may be utilized to inhibit transcription by RNA Polymerase II (Pol II), and in particular to disrupt the Super Elongation Complex (SEC). The compounds may be utilized in pharmaceutical compositions and methods for treating diseases and disorders associated with the biological activity of SEC, and in particular, diseases and disorders that are associated with high levels of expression of genes whose expression is SEC-dependent and that promote, support, or otherwise are required for the disease or disorder such as cancers.
                            本文揭示了可用于抑制RNA聚合酶II(Pol II)转录的化合物,特别是破坏超级延伸复合物(
SEC)的化合物。这些化合物可用于制备药物组合物和治疗与
SEC
生物活性相关的疾病和紊乱的方法,特别是与高
水平表达
SEC依赖
基因相关的促进、支持或其他对疾病或紊乱必要的疾病和紊乱,如癌症。